20101 results for «»
20101 results
Stratified treatment of INOCA: from the cathlab to the outpatient clinic
23 Mar 2021
Watch now Y. Appelman, B. De Bruyne and U. Sechtem in this series of webinars on ischemia and no obstructive coronary artery disease
The greatest advance in the next 40 years would be to remove the need for angioplasty
17 May 2017
Spencer B. King performed some of the first coronary angioplasty procedures in the USA—having recently received a thank-you from the first patient that he treated. He tells The Daily Wire that the steerable guidewire, rather than the stent, was the greatest advance in angioplasty and that...
Authors :
INOCA in specific scenarios
09 May 2021
Watch now E. Barbato, J. Escaned and M. Gulati in this series of webinars on ischemia and no obstructive coronary artery disease
Start treating refractory angina patients with Reducer therapy - Practical aspects
17 May 2022 – From EuroPCR 2022
Looking at a 75-year-old male patient with HTA, diabetes, and hypothyroidism, a history of coronary artery disease treated with PCI of the RCA, and a previous coronary angiography showing preserved LVEF and in-stent restenosis of the RCA, you will learn in this EuroPCR 2022 session how...
Marc Feldman
San Antonio, Texas, USA, United States of America
Sirolimus coated balloon and coronary artery disease: expanding the treatment indications
17 May 2022 – From EuroPCR 2022
Through a case presentation, as well as upcoming studies and rationale for the Food and Drug Administration, the aim of this EuroPCR 2022 session is to help you answer the following questions: how can the use of a sirolimus-coated DCB be expanded in new and challenging treatment indications? Why is...
Lifetime management of patients with severe aortic stenosis - Securing long-term benefits
17 May 2022 – From EuroPCR 2022
Watching this EuroPCR 2022 session on lifetime management of patients with aortic stenosis will help you understand the importance of the heart team in patient specific treatment and how procedural refinement may optimise long-term outcomes.
Stent failure: how to treat, how to prevent
18 May 2022 – From EuroPCR 2022
With 2 expert interviews, a stent failure case example, and a recorded best practice case to prevent stent failure in this EuroPCR 2022 session, understand why unraveling the mechanism of stent failure is essential for optimal treatment, receive tips and tricks to effectively treat stent failure,...
Incorporating coronary orbital atherectomy to my practice
18 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to examine the improvement of technology in the treatment of highly calcified coronary lesions: get a practical perspective on how to integrate and perform orbital atherectomy in your clinical practice, become aware of its differential aspects compared to other plaque preparation...
Coronary microvascular dysfunction in case examples: invisible, measurable, treatable
18 May 2022 – From EuroPCR 2022
In this very practical session from EuroPCR 2022 focusing on microcirculation, learn how to perform a step-by-step assessment of the coronary microcirculation in the cathlab, discuss the whole management of patients with coronary microvascular dysfunction (CMD), and understand how to use coronary flow reserve (CFR) and index...
Is PCI enough in STEMI?
18 May 2022 – From EuroPCR 2022
With study results and case presentations, in this EuroPCR 2022 session, our experts try to demonstrate the need for improved outcomes in STEMI, and enable you to understand how infarct size and microvascular obstruction impact these outcomes, and to learn about SuperSaturated Oxygen Therapy and the data supporting infarct...
Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from the TriClip bRIGHT study
20 May 2022 – From EuroPCR 2022
Philip Lurz speaks with Alessandro Sticchi about the 30-day results from the TriClip bRIGHT study on 300 subjects with symptomatic tricuspid regurgitation. He also shares his perspective on the future of edge to edge treatment in the tricuspid field.
First dedicated transcatheter leaflet splitting device from bench to first-in-man
20 May 2022 – From EuroPCR 2022
Pierre Deharo interviews Didier Tchétché on the first transcatheter leaflet splitting device (ShortCut device)which can be targeted for bicuspid aortic valves and valve-in-valve procedures.
Transcatheter tricuspid valve repair: CLASP TR study one-year results
19 May 2022 – From EuroPCR 2022
Alessandro Sticchi asks Rebecca Hahn about the one-year results of the CLASP TR study and the impact it will have on the management of tricuspid regurgitation.
Abbreviated DAPT after complex PCI in high bleeding risk patients
18 May 2022 – From EuroPCR 2022
Luis Ortega Paz interviews Pascal Vranckx on the background, main results and take-home messages from the sub-analysis of the MASTER DAPT study.
Hypertension management in 2022: Latest data on renal denervation
17 May 2022 – From EuroPCR 2022
Ali Nazmi Calik discusses with David Kandzari the current data on the catheter-based renal denervation treatment to reduce blood pressure in patients with hypertension. They discuss more specifically the results from SPYRAL HTN-ON MED 3-year data, the 3-year Global SYMPLICITY Registry and RADIANCE-HTN SOLO and TRIO...
DIStal vs. COnventional RADIAL access for coronary angiography and intervention - the DISCO Radial Trial
18 May 2022 – From EuroPCR 2022
David Rodrigues interviews Adel Aminian on the results from the DISCO Radial trial. This is the first large-scale multicenter randomized evidence comparing DRA to TRA in patients scheduled for coronary angiography or PCI with respect to the incidence of RAO at discharge.
JenaValve Trilogy for treatment of aortic regurgitation: worldwide first results
18 May 2022 – From EuroPCR 2022
Alexander Tamm shares with Alessandro Sticchi the results of the JenaValve Trilogy study, the first experience of implantation of the JenaValve device for treating aortic regurgitation.
Simplifying complex coronary interventions by adopting angiography-based physiology and a healing-targeted DES
19 May 2022 – From EuroPCR 2022
Consult this session to learn how to apply angio-based physiology to optimise patient selection for PCI, to discuss the impact of a healing-targeted DES on outcomes and DAPT duration, as well as to learn about the HT Supreme DES implantations in the (ongoing) QFR-guided, PIONEER IV trial.
State-of-the-art imaging for structural heart disease interventions
19 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session aims to focus on imaging and help understand what imaging has changed in recent years: learn how to perform pre-procedural planning and how advanced imaging can make procedures easier and safer.
